MIT spin­out Con­tin­u­us calls up­on Skan­s­ka to build MA site with fed­er­al de­fense mon­ey

A spin­out from an MIT lab has land­ed a deal with a Swedish de­vel­op­ment group to build a $125 mil­lion man­u­fac­tur­ing fa­cil­i­ty in Woburn, MA, just 15 miles out­side Boston.

Skan­s­ka signed a con­tract with Con­tin­u­us Phar­ma­ceu­ti­cals to ren­o­vate and build an­oth­er 50,000 square foot site up to cur­rent Good Man­u­fac­tur­ing Prac­tices stan­dards that will pro­duce dry ac­tive phar­ma­ceu­ti­cal in­gre­di­ents and fin­ished drug prod­ucts in both ster­ile in­jectable and tablets forms.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER